DC-SIGN

From Wikipedia, the free encyclopedia


CD209 molecule
PDB rendering based on 1k9i.
Available structures: 1k9i, 1sl4, 1sl5, 2b6b, 2it5, 2it6
Identifiers
Symbol(s) CD209; CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1; MGC129965
External IDs OMIM: 604672 MGI2157942 HomoloGene64372
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 30835 170786
Ensembl ENSG00000090659 ENSMUSG00000031494
Uniprot Q9NNX6 Q2TA59
Refseq NM_021155 (mRNA)
NP_066978 (protein)
NM_133238 (mRNA)
NP_573501 (protein)
Location Chr 19: 7.71 - 7.72 Mb Chr 8: 3.74 - 3.75 Mb
Pubmed search [1] [2]

DC-SIGN or CD209 is a C-type lectin receptor present on both macrophages and Dendritic cells.

DC-SIGN on macrophages recognises and binds to mannose type carbohydrates, a class of Pathogen associated molecular patterns PAMPs commonly found on viruses, bacteria and fungi. This binding interaction activates phagocytosis.[1]

On myeloid and pre-plasmacytoid dendritic cells DC-SIGN mediates dendritic cell rolling interactions with blood endothelium and activation of CD4+ T cells, as well as recognition of pathogen haptens.

Contents

[edit] Role in HIV infection

This molecule is involved in the initial stages of the Human Immunodeficiency Virus infection, as the HIV gp120 molecule causes co-internalization of the DC-SIGN molecule and HIV virion.

The dendritic cell then migrates to the cognate lymphoid organ, whereupon recycling of the DC-SIGN/HIV virion complex to the cell periphery facilitates HIV infection of T cells by interaction between DC-SIGN and ICAM-3.

[edit] References

  1. ^ McGreal E, Miller J, Gordon S (2005). "Ligand recognition by antigen-presenting cell C-type lectin receptors". Curr Opin Immunol 17 (1): 18–24. doi:10.1016/j.coi.2004.12.001. PMID 15653305. 

[edit] Further reading

  • Geijtenbeek TB, Engering A, Van Kooyk Y (2002). "DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology.". J. Leukoc. Biol. 71 (6): 921–31. PMID 12050176. 
  • Baribaud F, Doms RW, Pöhlmann S (2006). "The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?". Expert Opin. Ther. Targets 6 (4): 423–31. doi:10.1517/14728222.6.4.423. PMID 12223058. 
  • Bénichou S, Benmerah A (2003). "[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]". Med Sci (Paris) 19 (1): 100–6. PMID 12836198. 
  • van Kooyk Y, Geijtenbeek TB (2003). "DC-SIGN: escape mechanism for pathogens.". Nat. Rev. Immunol. 3 (9): 697–709. doi:10.1038/nri1182. PMID 12949494. 
  • Turville S, Wilkinson J, Cameron P, et al. (2004). "The role of dendritic cell C-type lectin receptors in HIV pathogenesis.". J. Leukoc. Biol. 74 (5): 710–8. doi:10.1189/jlb.0503208. PMID 12960229. 
  • Cambi A, Figdor CG (2004). "Dual function of C-type lectin-like receptors in the immune system.". Curr. Opin. Cell Biol. 15 (5): 539–46. PMID 14519388. 
  • Joseph AM, Kumar M, Mitra D (2005). "Nef: "necessary and enforcing factor" in HIV infection.". Curr. HIV Res. 3 (1): 87–94. PMID 15638726. 
  • Stove V, Verhasselt B (2006). "Modelling thymic HIV-1 Nef effects.". Curr. HIV Res. 4 (1): 57–64. PMID 16454711. 

[edit] External links